Skip to main content
. 2013 May 7;98(7):2952–2958. doi: 10.1210/jc.2013-1457

Table 1.

Clinical Characteristics of Adolescent Boys with AN and Normal-Weight Controlsa

AN Controls P Value
n 15 16
Age, y 16.01 ± 1.96 15.66 ± 1.86 NS
Bone age, y 16.18 ± 1.57 16.17 ± 2.28 NS
Bone age/chronological age 1.02 ± 0.11 1.03 ± 0.06 NS
Age at diagnosis of anorexia nervosa, y 15.2 ± 1.8
Duration since diagnosis, months 9.3 ± 14.2
Testicular size, mL 10.5 ± 6.1 18.7 ± 5.9 .002
Tanner stage for pubic hair 4.0 ± 1.5 4.5 ± 0.8 NS
Weight, kg 50.66 ± 9.81 61.99 ± 9.31 .002
Weight SDS −1.02 ± 0.20 0.13 ± 0.19 .0002
Height, cm 170.23 ± 10.39 170.56 ± 7.25 NS
Height SDS −0.14 ± 1.14 0.14 ± 1.25 NS
BMI, kg/m2 17.27 ± 1.69 21.27 ± 2.71 <.0001
BMI SDS −1.16 ± 0.42 0.09 ± 0.76 <.0001
Fat mass, kg 6.95 ± 2.30 9.98 ± 3.49 .008
Lean body mass, kg 43.65 ± 8.48 51.27 ± 7.83 .01
Percent body fat 13.2 ± 3.6 15.6 ± 4.1 .09
Hip BMD, g/cm3 0.86 ± 0.14 1.0 ± 0.13 .006
Hip BMD Z-score −1.11 ± 1.00 0.03 ± 0.75 .001
Hip BMD Z-score < −1, % 53.3 18.8 .05
Femoral Neck BMD, g/cm3 0.78 ± 0.11 0.90 ± 0.13 .01
Femoral Neck BMD Z-score −1.11 ± 0.84 −0.12 ± 0.86 .003
Femoral neck BMD Z-score <−1, % 60.0 12.5 .009
Trochanteric BMD, g/cm3 0.67 ± 0.11 0.79 ± 0.07 .0007
Trochanteric BMD Z-score −1.15 ± 0.83 −0.02 ± 0.60 .0001
Trochanteric BMD Z-score <−1, % 66.7 0 <.0001
Intertrochanteric BMD, g/cm3 0.98 ± 0.17 1.15 ± 0.17 .01
Intertrochanteric BMD Z-Score −0.99 ± 1.17 0.16 ± 0.82 .003
Intertrochanteric BMD Z-score <−1, % 53.3 12.5 .02
Testosterone, ng/dL 172.5 ± 142.1 445.0 ± 201.2 .0005
Estradiol, pg/mL 11.6 ± 4.5 18.6 ± 7.2 .006
IGF-I, ng/mL 456.7 ± 264.6 567.5 ± 244.3 NS

Abbreviation: NS, not significant.

a

Results are shown as mean ± SD or percent. P values < .1 are shown, and significant P values are in bold.

HHS Vulnerability Disclosure